G Aulagner
Overview
Explore the profile of G Aulagner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
283
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Coulibaly B, Gaillard C, Pelletier S, Guitton J, Fongoro S, Tangara M, et al.
Ann Pharm Fr
. 2022 Jun;
80(6):810-818.
PMID: 35662588
Infection which occurs in renal kidney failure patient have to be therapeutically managed immediately and the treatment must be aggressive to be quickly efficient. In Bamako (Mali). Posology adaptation cause...
2.
Barral M, Armoiry X, Boudour S, Aulagner G, Schott A, Turjman F, et al.
Rev Neurol (Paris)
. 2019 Sep;
176(3):180-188.
PMID: 31526554
Objectives: To determine the cost-effectiveness of stent retriever thrombectomy (SRT) added to standard of care (SOC) in large vessel occlusion (LVO) strokes, adopting the French societal perspective given the lack...
3.
Barral M, Boudour S, Viprey M, Giroudon C, Aulagner G, Schott A, et al.
Rev Neurol (Paris)
. 2018 May;
174(5):319-326.
PMID: 29706296
Background And Purpose: Endovascular thrombectomy has become the reference therapy for patients with large vessel occlusion (LVO). However, no meta-analysis including the THRACE Trial has yet been reported. Thus, the...
4.
Bauducel M, Piriou V, Dussart C, Aulagner G, Armoiry X
Ann Pharm Fr
. 2017 Mar;
75(4):276-284.
PMID: 28347475
Objectives: Phenylephrine, ephedrine and norepinephrine are the vasopressors most commonly used in the operating room to treat anaesthesia-induced hypotension. Two new diluted forms of phenylephrine were released in 2011 (500μg/10mL...
5.
Sainfort A, Denis-Hallouard I, Aulagner G, Nuiry O, Armoiry X
Ann Pharm Fr
. 2017 Mar;
75(5):398-407.
PMID: 28318504
Objectives: To present a method aimed to evaluate the economic impact associated with the use of medical devices (DM) not reimbursed in addition to diagnosis related groups (DRGs) tariffs using...
6.
Viprey M, Jeannin R, Piriou V, Chevalier P, Michel C, Aulagner G, et al.
J Clin Pharm Ther
. 2016 Oct;
42(1):58-63.
PMID: 27778374
What Is Known And Objective: The complex dose regimens of the direct-acting oral anticoagulants (DOAC) make their appropriate prescribing highly challenging. Inappropriate prescribing of the DOAC remains poorly addressed. We...
7.
Sainfort A, Denis Hallouard I, Hartmann D, Aulagner G, Francois Y, Tiffet O, et al.
J Visc Surg
. 2016 Sep;
153(6):403-417.
PMID: 27618702
Study Aim: To describe the main technical characteristics of biologic prostheses used for parietal reinforcement and to present the state of the art on their risk/benefit ratio. Methods: We conducted...
8.
Bernard-Arnoux F, Lamure M, Ducray F, Aulagner G, Honnorat J, Armoiry X
Neuro Oncol
. 2016 May;
18(8):1129-36.
PMID: 27177573
Background: There is strong concern about the costs associated with adding tumor-treating fields (TTF) therapy to standard first-line treatment for glioblastoma (GBM). Hence, we aimed to determine the cost-effectiveness of...
9.
Armoiry X, Carry P, Lehot J, Michel C, Aulagner G, Piriou V
Acta Anaesthesiol Scand
. 2016 Mar;
60(7):917-24.
PMID: 26935817
Background: Syringes of ephedrine are usually prepared ahead of time in order to reduce the time to injection. Commercial pre-filled syringes of ephedrine have been introduced to minimize the amount...
10.
Armoiry X, Carry P, Lehot J, Aulagner G, Piriou V
Anaesth Crit Care Pain Med
. 2016 Feb;
35(2):177-8.
PMID: 26862071
No abstract available.